home / stock / tkno / tkno news

TKNO News and Press, Alpha Teknova Inc. From 10/13/22

Stock Information
Company Name: Alpha Teknova Inc.
Stock Symbol: TKNO
Market: NASDAQ
Website: teknova.com
Menu
TKNO TKNO Quote TKNO Short TKNO News TKNO Articles TKNO Message Board
Get TKNO Alerts

News, Short Squeeze, Breakout and More Instantly...
TKNO - Teknova Announces Early Access Program for Novel Products to Address Critical Pain Points in Gene Therapy Bioproduction

HOLLISTER, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, announced the creati...
TKNO - Teknova to Present at 2022 Cell & Gene Meeting on the Mesa

HOLLISTER, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that...

TKNO - Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q2 2022 Results - Earnings Call Transcript

Alpha Teknova, Inc. (TKNO) Q2 2022 Earnings Conference Call August 10, 2022 04:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Finan...

TKNO - Alpha Teknova, Inc. 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Alpha Teknova, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Alpha Teknova, Inc. 2022 Q2 - Results - Earnings Call Presentation

TKNO - Alpha Teknova GAAP EPS of -$0.22 beats by $0.03, revenue of $11.7M beats by $0.85M

Alpha Teknova press release ( NASDAQ: TKNO ): Q2 GAAP EPS of -$0.22 beats by $0.03 . Revenue of $11.7M (+41.0% Y/Y) beats by $0.85M . 2022 Outlook: Teknova now anticipates total revenue of $38 million to $42 million ($47.17M consensus) For further det...

TKNO - Teknova Reports Second Quarter 2022 Financial Results

Second quarter 2022 total revenue was $11.7 million, up 41% year-over-year Cash position of $64.7 million supports ongoing investment in growth strategy Company updates 2022 revenue outlook to $38-42 million HOLLISTER, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Alpha Tekn...

TKNO - Teknova to Report Second Quarter 2022 Financial Results on August 10, 2022

HOLLISTER, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that...
TKNO - IQ, CSSE and OWLT among mid-day movers

Gainers: Revlon (REV) +98%. biote (BTMD) +61%. Cepton (CPTN) +40%. Alpha Teknova (TKNO) +23%. New Oriental Education & Technology (EDU) +23%. Owlet (OWLT) +21%. Belite Bio (BLTE) +21%. Kaival Brands Innovations Group (KAVL) +20%. iQIYI (IQ) +17%. NIO (NIO) +16%. Redbox Entertainment (RDBX...

TKNO - LAB, EAR and CHRA among mid-day movers

Gainers: Redbox Entertainment (RDBX) +37%. Vivid Seats (SEAT) +37%. VIQ Solutions (VQS) +29%. Modine Manufacturing (MOD) +28%. Eargo (EAR) +27%. Charah Solutions (CHRA) +23%. Baozun (BZUN) +21%. Alpha Teknova (TKNO) +20%. Standard BioTools (LAB) +20%. Losers: NRx Pharmaceuticals (NRXP) -63%. ...

TKNO - Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q1 2022 Results - Earnings Call Transcript

Alpha Teknova, Inc. (TKNO) Q1 2022 Earnings Conference Call May 11, 2022 04:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Part...
Previous 10 Next 10